| EP3430138 - MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 04.02.2022 Database last updated on 28.03.2026 | |
| Former | The patent has been granted Status updated on 19.02.2021 | ||
| Former | Grant of patent is intended Status updated on 01.10.2020 | ||
| Former | Examination is in progress Status updated on 16.11.2019 | ||
| Former | Request for examination was made Status updated on 21.12.2018 | ||
| Former | The international publication has been made Status updated on 22.09.2017 | ||
| Former | unknown Status updated on 22.02.2017 | Most recent event Tooltip | 19.12.2025 | Lapse of the patent in a contracting state New state(s): TR | published on 21.01.2026 [2026/04] | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2019/04] | Inventor(s) | 01 /
OLAYIOYE, Monilola c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | 02 /
HAUSSER, Angelika c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | 03 /
PIEPER, Lisa c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | 04 /
STROTBEK, Michaela c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | 05 /
WENGER, Till c/o Boehringer Ingelheim Pharma GmbH & Co.KG Bingerstrasse 173 55216 Ingelheim am Rhein / DE | [2021/12] |
| Former [2019/04] | 01 /
OLAYIOYE, Monilola c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | ||
| 02 /
HAUSSER, Angelika c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | |||
| 03 /
PIEPER, Lisa c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | |||
| 04 /
STROTBEK, Michaela c/o University of Stuttgart Institute of Cell Biology and Immunology Allmandring 31 70569 Stuttgart / DE | |||
| 05 /
WENGER, Till c/o Boehringer Ingelheim Pharma GmbH&Co.KG Bingerstrasse 173 55216 Ingelheim am Rhein / DE | Representative(s) | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2019/04] | Application number, filing date | 17704753.7 | 10.02.2017 | [2019/04] | WO2017EP53043 | Priority number, date | EP20160161253 | 18.03.2016 Original published format: EP 16161253 | [2019/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017157593 | Date: | 21.09.2017 | Language: | EN | [2017/38] | Type: | A1 Application with search report | No.: | EP3430138 | Date: | 23.01.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.09.2017 takes the place of the publication of the European patent application. | [2019/04] | Type: | B1 Patent specification | No.: | EP3430138 | Date: | 24.03.2021 | Language: | EN | [2021/12] | Search report(s) | International search report - published on: | EP | 21.09.2017 | Classification | IPC: | C12N15/11, C12P21/00, C12N1/00 | [2019/04] | CPC: |
C12N15/111 (EP,KR);
C12N5/0602 (KR);
C12N15/113 (US);
C07K14/4705 (EP,KR,US);
C07K16/00 (US);
C12N15/11 (US);
C12N15/1137 (US);
C12N15/85 (KR);
C12N9/1029 (EP,KR);
C12N9/1088 (US);
C12N9/22 (US);
C12P21/02 (EP,KR);
C12Y205/01018 (US);
C07K2319/00 (US);
C12N2310/122 (US);
C12N2310/14 (US);
C12N2310/20 (EP,KR,US);
C12N2310/531 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | SÄUGETIERZELLEN ZUR HERSTELLUNG EINES SEKRETIERTEN PROTEINS | [2019/04] | English: | MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN | [2019/04] | French: | CELLULES DE MAMMIFÈRES POUR PRODUIRE UNE PROTÉINE SÉCRÉTÉE | [2019/49] |
| Former [2019/04] | CELLULES DE MAMMIFÈRE DESTINÉES À LA PRODUCTION D'UNE PROTÉINE SÉCRÉTÉE | Entry into regional phase | 18.10.2018 | National basic fee paid | 18.10.2018 | Designation fee(s) paid | 18.10.2018 | Examination fee paid | Examination procedure | 18.10.2018 | Examination requested [2019/04] | 18.10.2018 | Date on which the examining division has become responsible | 11.04.2019 | Amendment by applicant (claims and/or description) | 20.11.2019 | Despatch of a communication from the examining division (Time limit: M04) | 11.03.2020 | Reply to a communication from the examining division | 02.10.2020 | Communication of intention to grant the patent | 29.01.2021 | Fee for grant paid | 29.01.2021 | Fee for publishing/printing paid | 29.01.2021 | Receipt of the translation of the claim(s) | Opposition(s) | 04.01.2022 | No opposition filed within time limit [2022/10] | Fees paid | Renewal fee | 28.02.2019 | Renewal fee patent year 03 | 02.03.2020 | Renewal fee patent year 04 | 10.02.2021 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 10.02.2017 | AL | 24.03.2021 | AT | 24.03.2021 | CY | 24.03.2021 | CZ | 24.03.2021 | DK | 24.03.2021 | EE | 24.03.2021 | ES | 24.03.2021 | FI | 24.03.2021 | HR | 24.03.2021 | IT | 24.03.2021 | LT | 24.03.2021 | LV | 24.03.2021 | MC | 24.03.2021 | MK | 24.03.2021 | MT | 24.03.2021 | NL | 24.03.2021 | PL | 24.03.2021 | RO | 24.03.2021 | RS | 24.03.2021 | SE | 24.03.2021 | SI | 24.03.2021 | SK | 24.03.2021 | SM | 24.03.2021 | TR | 24.03.2021 | BG | 24.06.2021 | NO | 24.06.2021 | GR | 25.06.2021 | IS | 24.07.2021 | PT | 26.07.2021 | [2026/04] |
| Former [2024/44] | HU | 10.02.2017 | |
| AL | 24.03.2021 | ||
| AT | 24.03.2021 | ||
| CY | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| IT | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| MK | 24.03.2021 | ||
| MT | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2024/22] | HU | 10.02.2017 | |
| AL | 24.03.2021 | ||
| AT | 24.03.2021 | ||
| CY | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| IT | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| MK | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2024/20] | HU | 10.02.2017 | |
| AL | 24.03.2021 | ||
| AT | 24.03.2021 | ||
| CY | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| IT | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2024/18] | HU | 10.02.2017 | |
| AL | 24.03.2021 | ||
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| IT | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2023/10] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| IT | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2022/44] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| MC | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2022/23] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2022/13] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SI | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| PT | 26.07.2021 | ||
| IS | 24.12.2021 | ||
| Former [2022/10] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| PT | 26.07.2021 | ||
| IS | 24.12.2021 | ||
| Former [2022/08] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| DK | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| ES | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2022/07] | AL | 24.03.2021 | |
| AT | 24.03.2021 | ||
| CZ | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2021/52] | AT | 24.03.2021 | |
| CZ | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| PL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2021/51] | AT | 24.03.2021 | |
| CZ | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| IS | 24.07.2021 | ||
| PT | 26.07.2021 | ||
| Former [2021/50] | AT | 24.03.2021 | |
| CZ | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| RO | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SK | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| PT | 26.07.2021 | ||
| Former [2021/48] | AT | 24.03.2021 | |
| CZ | 24.03.2021 | ||
| EE | 24.03.2021 | ||
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/46] | AT | 24.03.2021 | |
| FI | 24.03.2021 | ||
| HR | 24.03.2021 | ||
| LT | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| SM | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/43] | FI | 24.03.2021 | |
| HR | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| NL | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/38] | FI | 24.03.2021 | |
| HR | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| SE | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/37] | FI | 24.03.2021 | |
| HR | 24.03.2021 | ||
| LV | 24.03.2021 | ||
| RS | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/36] | FI | 24.03.2021 | |
| HR | 24.03.2021 | ||
| BG | 24.06.2021 | ||
| NO | 24.06.2021 | ||
| GR | 25.06.2021 | ||
| Former [2021/35] | FI | 24.03.2021 | |
| HR | 24.03.2021 | ||
| NO | 24.06.2021 | ||
| Former [2021/33] | FI | 24.03.2021 | |
| NO | 24.06.2021 | Cited in | International search | [A] WO2009062789 (BOEHRINGER INGELHEIM PHARMA et al.) [A] 1-15 * the whole document * |